Reply: Pharmacologic therapies for infantile hemangioma: Is there a rational basis?

Plastic and Reconstructive Surgery

Volumn 129, Issue 4, 2012, Pages

  Itinteang, Tinte ^a   Withers, Aaron H J ^a   Leadbitter, Philip ^a   Day, Darren J ^b   Tan, Swee T ^a  

^a HUTT HOSPITAL   (New Zealand)

^b Wellington Regional Plastic   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859328551     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318245e7cd     Document Type: Letter

References (13)

1. Itinteang T, Withers AH, Leadbitter P, Day DJ, Tan ST. Pharmacologic therapies for infantile hemangioma: Is there a rational basis? Plast Reconstr Surg. 2011;128:499-507.
2. Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg. 2009;20(Suppl 1):695-697.
3. Itinteang T, Tan ST, Guthrie S, et al. A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma. J Clin Pathol. 2011;64:870-874.
4. Itinteang T, Brasch HD, Tan ST, Day DJ. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg. 2011;64:759-765.
5. Itinteang T, Tan ST, Brasch HD, Day DJ. Haemogenic endothelium in infantile haemangioma. J Clin Pathol. 2010;63: 982-986.
6. Itinteang T, Vishvanath A, Day DJ, Tan ST. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol. 2011;64: 232-236.
7. Vishvanath A, Itinteang T, Tan ST, Day DJ. Infantile haemangioma expresses tumour necrosis factor-related apoptosisinducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor B ligand (RANKL). Histopathology 2011;59:397-406.
8. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg. 2011;64: 292-299.
9. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function. Pediatrics 2011;127:e772-e776.
10. Tan ST, Itinteang T, Day DJ, O'Donnell C, et al. Treatment of infantile haemangioma with low dose captopril. Submitted for publication.
11. Itinteang T, Tan ST, Brasch HD, Day DJ. Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma. J Clin Pathol. 2010;63:771-776.
12. Itinteang T, Tan ST, Brasch HD, Vishvanath A, Day DJ. Primitive erythropoiesis in infantile haemangioma. Br J Dermatol. 2011;164:1097-1100.
13. Itinteang T, Tan ST, Brasch HD, et al. Infantile haemangioma expresses embryonic stem cell markers. Submitted for publication.